New York, NY · Founded 2016 · Privately Held (backing)
Developer of a synthetic virology platform designed to engineer oncolytic viral therapies for cancer treatment. Humane Genomics is based in New York, NY and was founded in 2016. Its last reported valuation was $17 million in Feb 2025. It has raised $8.1 million.
Last reported valuation
$17.0M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—
Team — not yet on record
No current team members for Humane Genomics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Humane Genomics with a free account
·The complete investor list: 17 names
·Watch Humane Genomics: the Monday email on marks, rounds and moves
